Why This Vaccine Pioneer is Turning Heads on Wall Street
Valneva SE, a specialized vaccine manufacturer, is noted for its innovative biological solutions tackling unmet medical needs. The stock price recently fell to $7.17, promising potential for adventurous investors with…